ES549299A0 - Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas. - Google Patents

Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.

Info

Publication number
ES549299A0
ES549299A0 ES549299A ES549299A ES549299A0 ES 549299 A0 ES549299 A0 ES 549299A0 ES 549299 A ES549299 A ES 549299A ES 549299 A ES549299 A ES 549299A ES 549299 A0 ES549299 A0 ES 549299A0
Authority
ES
Spain
Prior art keywords
pirazolin
heteroaril
onas
aril
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549299A
Other languages
English (en)
Other versions
ES8801243A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8801243A1 publication Critical patent/ES8801243A1/es
Publication of ES549299A0 publication Critical patent/ES549299A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES549299A 1984-11-28 1985-11-26 Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas. Expired ES8801243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843443308 DE3443308A1 (de) 1984-11-28 1984-11-28 1-heteroaryl-4-aryl-pyrazolin-5-one zur verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8801243A1 ES8801243A1 (es) 1987-12-16
ES549299A0 true ES549299A0 (es) 1987-12-16

Family

ID=6251331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549299A Expired ES8801243A1 (es) 1984-11-28 1985-11-26 Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.

Country Status (7)

Country Link
US (1) US4698344A (es)
EP (1) EP0183159A3 (es)
JP (1) JPS61137878A (es)
DE (1) DE3443308A1 (es)
ES (1) ES8801243A1 (es)
IL (1) IL77138A0 (es)
ZA (1) ZA859065B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
USRE35801E (en) * 1985-05-20 1998-05-19 Mitsubishi Chemical Corporation Prophylactic and therapeutic composition for circulatory disorders and method of treatment
DE3527157A1 (de) * 1985-07-30 1987-02-12 Bayer Ag 1-heteroaryl-4-aryl-pyrazol-derivate
DE3718526A1 (de) * 1987-06-03 1988-12-22 Basf Ag Substituierte 5-amino-1-(pyrimidin-2-yl)-1h-pyrazole
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
US5214191A (en) * 1990-05-22 1993-05-25 Cortech, Inc. Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
US5663416A (en) * 1990-05-22 1997-09-02 Cortech Inc. Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
GB9017351D0 (en) * 1990-08-08 1990-09-19 Wellcome Found Medicaments for treatment of atherosclerosis
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
DE102005019712A1 (de) * 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102006050513A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substitiuierte Dihydropyrazolone und ihre Verwendung
DE102006050515A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
DE102007044032A1 (de) 2007-09-14 2009-03-19 Bayer Healthcare Ag Substituierte heterocyclische Verbindungen und ihre Verwendung
DE102007048447A1 (de) 2007-10-10 2009-04-16 Bayer Healthcare Ag Substituierte Dihydropyrazolthione und ihre Verwendung
FR2949466A1 (fr) * 2009-08-28 2011-03-04 Sanofi Aventis Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif
DE102010044131A1 (de) 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat
MX370388B (es) 2013-03-29 2019-12-11 Takeda Pharmaceuticals Co Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhibidores de la enzima propil hidroxilasa (phd).
WO2019141957A1 (en) * 2018-01-19 2019-07-25 Cado Biotechnology Ivs N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
AU2021240044A1 (en) * 2020-03-20 2022-11-17 Akebia Therapeutics, Inc. PHD inhibitor compounds, compositions, and use
JP2023518543A (ja) * 2020-03-20 2023-05-02 アケビア セラピューティクス インコーポレイテッド Ｐｈｄ阻害剤化合物、組成物、及びそれらの使用
CN120535464B (zh) * 2025-07-17 2025-10-14 江西中医药大学 一种多卤代吡唑啉酮及其电化学合成方法与抗炎用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1112984B (de) * 1956-06-27 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Pyrazolonderivaten
GB1115887A (en) * 1965-04-23 1968-05-29 Daiichi Seiyaku Company Ltd A substituted 3-pyrazoline-5-one and a 5-alkoxy derivative thereof
US4032646A (en) * 1973-04-17 1977-06-28 Bayer Aktiengesellschaft Pyrazol-5-ones
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
DE3419127A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen 1-heteroaryl-4-aryl-pyrazolin-5-one
DE3430511A1 (de) * 1984-08-18 1986-02-27 Bayer Ag, 5090 Leverkusen Waschbestaendige, antimikrobiell wirksame fasern und faeden und ihre herstellung

Also Published As

Publication number Publication date
ES8801243A1 (es) 1987-12-16
EP0183159A3 (de) 1987-01-14
EP0183159A2 (de) 1986-06-04
DE3443308A1 (de) 1986-05-28
JPS61137878A (ja) 1986-06-25
IL77138A0 (en) 1986-04-29
US4698344A (en) 1987-10-06
ZA859065B (en) 1986-07-30

Similar Documents

Publication Publication Date Title
ES540597A0 (es) Procedimiento para la obtencion de piridonas.
ES549299A0 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
ES551924A0 (es) Procedimiento para la preracion de ester-2-(5-cloroquinolin-8-iloxi-5-acetico-alquilico.
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES557316A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidrovalerilo.
ES539822A0 (es) Procedimiento para la preparacion de pirazolopiridinas.
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
FI863618A7 (fi) Laekemedel foer haestar.
ES542421A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- quinolina-1-ilcarbonilimidazol.
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES544459A0 (es) Procedimiento para la obtencion de benzo -c- -1,8-naftiridi-nas
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES549429A0 (es) Procedimiento para la obtencion de acemetacina.
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES546563A0 (es) Procedimiento para la obtencion de 1-(2-oxiamino-sulfonil- fenilsulfoni)-3-heteroaril-ureas